An update on the changing epidemiology and metabolic risk factors in pediatric kidney stone disease

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 8, 2011, Pages 2062-2068

  Sas, David J ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ETHNICITY; INCIDENCE; KIDNEY FUNCTION; METABOLISM; NEPHROLITHIASIS; RISK FACTOR; STONE FORMATION; URINALYSIS;

ADOLESCENT; AGE FACTORS; CALCIUM OXALATE; CHILD; CHILD, PRESCHOOL; CONTINENTAL POPULATION GROUPS; CRYSTALLIZATION; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; KIDNEY; MALE; NEPHROLITHIASIS; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; URETER;

EID: 80051562551     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.11191210     Document Type: Article

References (96)

1. Gillen DL, Coe FL, Worcester EM: Nephrolithiasis and increased blood pressure among females with high body mass index. Am J Kidney Dis 46: 263-269, 2005
2. Gillen DL, Worcester EM, Coe FL: Decreased renal function among adults with a history of nephrolithiasis: A study of NHANES III. Kidney Int 67: 685-690, 2005
3. Rule AD, Bergstralh EJ, Melton LJ 3rd, Li X, Weaver AL, Lieske JC: Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol 4: 804-811, 2009
4. Worcester EM, Parks JH, Evan AP, Coe FL: Renal function in patients with nephrolithiasis. J Urol 176: 600-603, discussion 603, 2006
5. Lotan Y: Economics and cost of care of stone disease. Adv Chronic Kidney Dis 16: 5-10, 2009
6. Sas DJ, Hulsey TC, Shatat IF, Orak JK: Incidence of kidney stones in children evaluated in the ER is increasing. J Pediatr 157: 132-137, 2010
7. Bush NC, Xu L, Brown BJ, Holzer MS, Gingrich A, Schuler B, Tong L, Baker LA: Hospitalizations for pediatric stone disease in United States, 2002-2007. J Urol 183: 1151-1156, 2010
8. Routh JC, Graham DA, Nelson CP: Epidemiological trends in pediatric urolithiasis at United States freestanding pediatric hospitals. J Urol 184: 1100-1104, 2010
9. Edvardsson V, Elidottir H, Indridason OS, Palsson R: High incidence of kidney stones in Icelandic children. Pediatr Nephrol 20: 940-944, 2005
10. Yasui T, Iguchi M, Suzuki S, Kohri K: Prevalence and epidemiological characteristics of urolithiasis in Japan: National trends between 1965 and 2005. Urology 71: 209-213, 2008
11. Lieske JC, Pena de la Vega LS, Slezak JM, Bergstralh EJ, Leibson CL, Ho KL, Gettman MT: Renal stone epidemiology in Rochester, Minnesota: An update. Kidney Int 69: 760-764, 2006
12. Curhan GC, Willett WC, Rimm EB, Stampfer MJ: A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 328: 833-838, 1993
13. Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ: Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med 126: 497-504, 1997
14. Pearle MS, Calhoun EA, Curhan GC: Urologic diseases in America project: Urolithiasis. J Urol 173: 848-857, 2005
15. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC: Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 63: 1817-1823, 2003
16. Novak TE, Lakshmanan Y, Trock BJ, Gearhart JP, Matlaga BR: Sex prevalence of pediatric kidney stone disease in the United States: An epidemiologic investigation. Urology 74: 104-107, 2009
17. Mente A, Honey RJ, McLaughlin JR, Bull SB, Logan AG: Ethnic differences in relative risk of idiopathic calcium nephrolithiasis in North America. J Urol 178: 1992-1997, discussion 1997, 2007
18. Curhan GC: Epidemiology of stone disease. Urol Clin North Am 34: 287-293, 2007
19. Pietrow PK, Pope JC 4th, Adams MC, Shyr Y, Brock JW 3rd: Clinical outcome of pediatric stone disease. J Urol 167: 670-673, 2002
20. Kalorin CM, Zabinski A, Okpareke I, White M, Kogan BA: Pediatric urinary stone disease: Does age matter? J Urol 181: 2267-2271, discussion 2271, 2009
21. Coward RJ, Peters CJ, Duffy PG, Corry D, Kellett MJ, Choong S, van't Hoff WG: Epidemiology of paediatric renal stone disease in the UK. Arch Dis Child 88: 962-965, 2003
22. Milliner DS, Murphy ME: Urolithiasis in pediatric patients. Mayo Clin Proc 68: 241-248, 1993
23. VanDervoort K, Wiesen J, Frank R, Vento S, Crosby V, Chandra M, Trachtman H: Urolithiasis in pediatric patients: A single center study of incidence, clinical presentation and outcome. J Urol 177: 2300-2305, 2007
24. Persaud AC, Stevenson MD, McMahon DR, Christopher NC: Pediatric urolithiasis: Clinical predictors in the emergency department. Pediatrics 124: 888-894, 2009
25. Soucie JM, Coates RJ, McClellan W, Austin H, Thun M: Relation between geographic variability in kidney stones prevalence and risk factors for stones. Am J Epidemiol 143: 487-495, 1996
26. Perrone HC, dos Santos DR, Santos MV, Pinheiro ME, Toporovski J, Ramos OL, Schor N: Urolithiasis in childhood: Metabolic evaluation. Pediatr Nephrol 6: 54-56, 1992
27. Naseri M, Varasteh AR, Alamdaran SA: Metabolic factors associated with urinary calculi in children. Iran J Kidney Dis 4: 32-38, 2010
28. Spivacow FR, Negri AL, del Valle EE, Calvino I, Fradinger E, Zanchetta JR: Metabolic risk factors in children with kidney stone disease. Pediatr Nephrol 23: 1129-1133, 2008
29. Polinsky MS, Kaiser BA, Baluarte HJ: Urolithiasis in childhood. Pediatr Clin North Am 34: 683-710, 1987 30. Cameron MA, Sakhaee K, Moe OW: Nephrolithiasis in children. Pediatr Nephrol 20: 1587-1592, 2005
30. Pak CY, Poindexter JR, Adams-Huet B, Pearle MS: Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med 115: 26-32, 2003
31. Defoor W, Asplin J, Jackson E, Jackson C, Reddy P, Sheldon C, Minevich E: Results of a prospective trial to compare normal urine supersaturation in children and adults. J Urol 174: 1708-1710, 2005
32. Borawski KM, Sur RL, Miller OF, Pak CY, Preminger GM, Kolon TF: Urinary reference values for stone risk factors in children. J Urol 179: 290-294, discussion 294, 2008
33. Maalouf NM, Cameron MA, Moe OW, Sakhaee K: Novel insights into the pathogenesis of uric acid nephrolithiasis. Curr Opin Nephrol Hypertens 13: 181-189, 2004
34. Coe FL, Evan A, Worcester E: Kidney stone disease. J Clin Invest 115: 2598-2608, 2005
35. Battino BS, DeFoor W, Coe F, Tackett L, Erhard M, Wacksman J, Sheldon CA, Minevich E: Metabolic evaluation of children with urolithiasis: Are adult references for supersaturation appropriate? J Urol 168: 2568-2571, 2002
36. DeFoor WR, Jackson E, Minevich E, Caillat A, Reddy P, Sheldon C, Asplin J: The risk of recurrent urolithiasis in children is dependent on urinary calcium and citrate. Urology 76: 242-245, 2010
37. Langley SE, Fry CH: Differences in the free Ca2+ in undiluted urine from stone formers and normal subjects using a new generation of ion-selective electrodes. Br J Urol 75: 288-295, 1995
38. DeFoor W, Asplin J, Jackson E, Jackson C, Reddy P, Sheldon C, Erhard M, Minevich E: Urinary metabolic evaluations in normal and stone forming children. J Urol 176: 1793-1796, 2006
39. Sikora P, Zajaczkowska M, Hoppe B: Assessment of crystallization risk formulas in pediatric calcium stone-formers. Pediatr Nephrol 24: 1997-2003, 2009
40. DeFoor W, Minevich E, Jackson E, Reddy P, Clark C, Sheldon C, Asplin J: Urinary metabolic evaluations in solitary and recurrent stone forming children. J Urol 179: 2369-2372, 2008
41. Pak CY, Adams-Huet B, Poindexter JR, Pearle MS, Peterson RD, Moe OW: Rapid Communication: Relative effect of urinary calcium and oxalate on saturation of calcium oxalate. Kidney Int 66: 2032-2037, 2004
42. Penniston KL, Nakada SY: Effect of dietary changes on urinary oxalate excretion and calcium oxalate supersaturation in patients with hyperoxaluric stone formation. Urology 73: 484-489, 2009
43. Neuhaus TJ, Belzer T, Blau N, Hoppe B, Sidhu H, Leumann E: Urinary oxalate excretion in urolithiasis and nephrocalcinosis. Arch Dis Child 82: 322-326, 2000
44. Evan A, Lingeman J, Coe FL, Worcester E: Randall's plaque: Pathogenesis and role in calcium oxalate nephrolithiasis. Kidney Int 69: 1313-1318, 2006
45. Coe FL: Hyperuricosuric calcium oxalate nephrolithiasis. Kidney Int 13: 418-426, 1978
46. Miller LA, Noe HN, Stapleton FB: Uric acid excretion in children with urolithiasis. J Pediatr 115: 923-926, 1989
47. Miller LA, Stapleton FB: Urinary volume in children with urolithiasis. J Urol 141: 918-920, 1989
48. Hallson PC, Rose GA, Sulaiman S: Raising urinary citrate lowers calcium oxalate and calcium phosphate crystal formation in whole urine. Urol Int 38: 179-181, 1983
49. Tiselius HG, Berg C, Fornander AM, Nilsson MA: Effects of citrate on the different phases of calcium oxalate crystallization. Scanning Microsc 7: 381-389, discussion 389-390, 1993
50. Akcay T, Konukoglu D, Celik C: Hypocitraturia in patients with urolithiasis. Arch Dis Child 74: 350-351, 1996
51. Tekin A, Tekgul S, Atsu N, Sahin A, Ozen H, Bakkaloglu M: A study of the etiology of idiopathic calcium urolithiasis in children: Hypocitruria is the most important risk factor. J Urol 164: 162-165, 2000
52. Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CY: Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 150: 1761-1764, 1993
53. Ettinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A: Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 158: 2069-2073, 1997
54. Jorgensen FS: The urinary excretion and serum concentration of calcium, magnesium, sodium and phosphate in male pa-tients with recurring renal stone formation. Scand J Urol Nephrol 9: 243-248, 1975
55. Siener R, Schade N, Nicolay C, von Unruh GE, Hesse A: The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients. J Urol 173: 1601-1605, 2005
56. Tefekli A, Esen T, Ziylan O, Erol B, Armagan A, Ander H, Akinci M: Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: Is there any difference? Urol Int 70: 273-277, 2003
57. Ettinger B, Citron JT, Livermore B, Dolman LI: Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J Urol 139: 679-684, 1988
58. Kato Y, Yamaguchi S, Yachiku S, Nakazono S, Hori J, Wada N, Hou K: Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis. Urology 63: 7-11, discussion 11-12, 2004
59. Ryall RL: Glycosaminoglycans, proteins, and stone formation: Adult themes and child's play. Pediatr Nephrol 10: 656-666, 1996
60. Hess B, Nakagawa Y, Parks JH, Coe FL: Molecular abnormality of Tamm-Horsfall glycoprotein in calcium oxalate nephrolithiasis. Am J Physiol 260: F569-F578, 1991
61. Fleisch H, Bisaz S: Mechanism of calcification: Inhibitory role of pyrophosphate. Nature 195: 911, 1962
62. Coe FL, Nakagawa Y, Asplin J, Parks JH: Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis. Miner Electrolyte Metab 20: 378-384, 1994
63. Asplin JR, Arsenault D, Parks JH, Coe FL, Hoyer JR: Contribution of human uropontin to inhibition of calcium oxalate crystallization. Kidney Int 53: 194-199, 1998
64. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM: Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295: 1549-1555, 2006
65. Maalouf NM, Sakhaee K, Parks JH, Coe FL, Adams-Huet B, Pak CY: Association of urinary pH with body weight in nephrolithiasis. Kidney Int 65: 1422-1425, 2004
66. Siener R, Glatz S, Nicolay C, Hesse A: The role of overweight and obesity in calcium oxalate stone formation. Obes Res 12: 106-113, 2004
67. Taylor EN, Curhan GC: Body size and 24-hour urine composition. Am J Kidney Dis 48: 905-915, 2006
68. Taylor EN, Stampfer MJ, Curhan GC: Obesity, weight gain, and the risk of kidney stones. JAMA 293: 455-462, 2005
69. West B, Luke A, Durazo-Arvizu RA, Cao G, Shoham D, Kramer H: Metabolic syndrome and self-reported history of kidney stones: The National Health and Nutrition Examination Survey (NHANES III) 1988-1994. Am J Kidney Dis 51: 741-747, 2008
70. Daudon M, Lacour B, Jungers P: Influence of body size on urinary stone composition in men and women. Urol Res 34: 193-199, 2006
71. Negri AL, Spivacow FR, Del Valle EE, Forrester M, Rosende G, Pinduli I: Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers. Urol Res 36: 303-307, 2008
72. Negri AL, Spivacow R, Del Valle E, Pinduli I, Marino A, Fradinger E, Zanchetta JR: Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers. Urol Res 35: 247-251, 2007
73. Powell CR, Stoller ML, Schwartz BF, Kane C, Gentle DL, Bruce JE, Leslie SW: Impact of body weight on urinary electrolytes in urinary stone formers. Urology 55: 825-830, 2000
74. Sarica K, Eryildirim B, Yencilek F, Kuyumcuoglu U: Role of overweight status on stone-forming risk factors in children: A prospective study. Urology 73: 1003-1007, 2009
75. Kieran K, Giel DW, Morris BJ, Wan JY, Tidwell CD, Giem A, Jerkins GR, Williams MA: Pediatric urolithiasis: Does body mass index influence stone presentation and treatment? J Urol 184: 1810-1815, 2010
76. Data Resource Center for Child and Adolescent Health: Child and Adolescent Health Measurement Initiative: Child Health Measures for Tennessee, 2007. http://www.childhealthdata.org/ content/Default.aspx. Accessed December 17, 2010
77. Eisner BH, Eisenberg ML, Stoller ML: Influence of body mass index on quantitative 24-hour urine chemistry studies in children with nephrolithiasis. J Urol 182: 1142-1145, 2009
78. Briefel RR, Johnson CL: Secular trends in dietary intake in the United States. Annu Rev Nutr 24: 401-431, 2004
79. Clark MA, Fox MK: Nutritional quality of the diets of US public school children and the role of the school meal programs. J Am Diet Assoc 109: S44-S56, 2009
80. Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A: Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 346: 77-84, 2002
81. Taylor EN, Fung TT, Curhan GC: DASH-style diet associates with reduced risk for kidney stones. J Am Soc Nephrol 20: 2253-2259, 2009
82. Breslau NA, McGuire JL, Zerwekh JE, Pak CY: The role of dietary sodium on renal excretion and intestinal absorption of calcium and on vitamin D metabolism. J Clin Endocrinol Metab 55: 369-373, 1982
83. Nordin BE, Need AG, Morris HA, Horowitz M: The nature and significance of the relationship between urinary sodium and urinary calcium in women. J Nutr 123: 1615-1622, 1993
84. Osorio AV, Alon US: The relationship between urinary calcium, sodium, and potassium excretion and the role of potassium in treating idiopathic hypercalciuria. Pediatrics 100: 675-681, 1997
85. Sakhaee K, Harvey JA, Padalino PK, Whitson P, Pak CY: The potential role of salt abuse on the risk for kidney stone formation. J Urol 150: 310-312, 1993
86. Keller KL, Kirzner J, Pietrobelli A, St Onge MP, Faith MS: Increased sweetened beverage intake is associated with reduced milk and calcium intake in 3-to 7-year-old children at multi-item laboratory lunches. J Am Diet Assoc 109: 497-501, 2009
87. Rajeshwari R, Yang SJ, Nicklas TA, Berenson GS: Secular trends in children's sweetened-beverage consumption (1973 to 1994): The Bogalusa Heart Study. J Am Diet Assoc 105: 208-214, 2005
88. Taylor EN, Stampfer MJ, Curhan GC: Dietary factors and the risk of incident kidney stones in men: New insights after 14 years of follow-up. J Am Soc Nephrol 15: 3225-3232, 2004
89. Kant AK, Graubard BI: Contributors of water intake in US children and adolescents: Associations with dietary and meal characteristics-National Health and Nutrition Examination Survey 2005-2006. Am J Clin Nutr 92: 887-896, 2010
90. Taylor EN, Curhan GC: Fructose consumption and the risk of kidney stones. Kidney Int 73: 207-212, 2008
91. Knight J, Assimos DG, Easter L, Holmes RP: Metabolism of fructose to oxalate and glycolate. Horm Metab Res 42: 868-873, 2010
92. Marriott BP, Cole N, Lee E: National estimates of dietary fructose intake increased from 1977 to 2004 in the United States. J Nutr 139: 1228S-1235S, 2009
93. Kaufman DW, Kelly JP, Curhan GC, Anderson TE, Dretler SP, Preminger GM, Cave DR: Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. J Am Soc Nephrol 19: 1197-1203, 2008
94. Sidhu H, Hoppe B, Hesse A, Tenbrock K, Bromme S, Rietschel E, Peck AB: Absence of Oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria. Lancet 352: 1026-1029, 1998
95. Grijalva CG, Nuorti JP, Griffin MR: Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA 302: 758-766, 2009
96. McCaig LF, Besser RE, Hughes JM: Trends in antimicrobial prescribing rates for children and adolescents. JAMA 287: 3096-3102, 2002